The Colorado HIV-1 Training Program (CHRTP) provides basic, translational and clinical AIDS-related postdoctoral training under the direction of a broadly based group of faculty actively engaged in AIDS research at the University of Colorado at Denver and Health Sciences Center, and affiliated institutions. The Training program has supported two MD post doctoral fellows per year since it inception in 1992. In 2002 the trainee pool was broadened to include a postdoctoral fellow with a PhD degree. The CHRTP has provided critical career development support for an outstanding group of 23 postdoctoral fellows over the past 15 years. The present application builds on the prior accomplishments of the CHRTP to provide a training program that will produce laboratory and clinical scientists who are better able to address evolving issues in the global HIV epidemic. The scope of the training program will be expanded to utilize the recent growth of HIV-related research expertise in pharmacy and nursing at UCDHSC, and basic and translational HIV-related research at the University of Colorado, Boulder and Colorado State University Campuses. The revised training program will be better equipped to train basic and clinical scientists from diverse disciplines and better prepare them for integrative and collaborative research careers in the AIDS field. The CHRTP will be coordinated by the Adult Infectious Disease Division at UCDHSC. Forty participating faculty located within seven institutions in Colorado, South Africa and Zimbabwe will serve as research mentors and advisors for potential trainees. The CHRTP will be directed by the Program Director who will be assisted by two Associate Program Directors. An Advisory Committee composed of five faculty with expertise representative of the diverse areas of training will advise the Program Directors. The success of the program will be evaluated on the basis of the extent to which it facilitates the career development of individuals who bed come productive member of the AIDS research community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007447-18
Application #
7640787
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Rosario, Joana A
Project Start
1992-09-30
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
18
Fiscal Year
2009
Total Cost
$202,159
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Anderson, Peter L; Liu, Albert Y; Castillo-Mancilla, Jose R et al. (2018) Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy. Antimicrob Agents Chemother 62:
Seifert, Sharon M; Castillo-Mancilla, Jose R; Erlandson, Kristine et al. (2018) Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy. J Acquir Immune Defic Syndr 77:295-298
Miller, Shannon M; Miles, Brodie; Guo, Kejun et al. (2017) Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1. J Virol 91:
Seifert, Sharon M; Chen, Xinhui; Meditz, Amie L et al. (2016) Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State. AIDS Res Hum Retroviruses 32:981-991
Miles, Brodie; Connick, Elizabeth (2016) TFH in HIV Latency and as Sources of Replication-Competent Virus. Trends Microbiol 24:338-344
Smith, Christiana; Weinberg, Adriana; Forster, Jeri E et al. (2016) Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infect Dis Obstet Gynecol 2016:9848041
Castillo-Mancilla, Jose; Seifert, Sharon; Campbell, Kayla et al. (2016) Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing. Antimicrob Agents Chemother 60:6692-6697
Chen, Xinhui; Castillo-Mancilla, Jose R; Seifert, Sharon M et al. (2016) Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine. Antimicrob Agents Chemother 60:5387-92
Kohler, Stephanie L; Pham, Michael N; Folkvord, Joy M et al. (2016) Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication. J Immunol 196:2711-22
Meditz, Amie L; Palmer, Claire; Predhomme, Julie et al. (2015) Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen. AIDS Res Hum Retroviruses 31:1015-22

Showing the most recent 10 out of 48 publications